{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:16:21Z","timestamp":1776485781313,"version":"3.51.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1007\/s11926-004-0059-3","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T14:06:52Z","timestamp":1180793212000},"page":"141-148","source":"Crossref","is-referenced-by-count":28,"title":["The pathogenesis of fibrosis and renal disease in scleroderma: Recent insights from glomerulosclerosis"],"prefix":"10.1007","volume":"6","author":[{"given":"Sungchun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.61.8.682","volume":"61","author":"R Livi","year":"2002","unstructured":"Livi R, Teghini L, Pignone A, et al.: Renal functional reserve is impaired in patients with systemic sclerosis without clinical sings of kidney involvement. Ann Rheum Dis 2002, 61:682.","journal-title":"Ann Rheum Dis"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"S637","DOI":"10.1067\/mai.2003.126","volume":"111","author":"R Cunard","year":"2003","unstructured":"Cunard R, Kelly CJ: Immune-related renal disease. J Allergy Clin Immunol 2003, 111:S637.","journal-title":"J Allergy Clin Immunol"},{"key":"59_CR3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","volume":"29","author":"VD Steen","year":"2003","unstructured":"Steen VD: Scleroderma renal crisis. Rheum Dis Clin North Am 2003, 29:315.","journal-title":"Rheum Dis Clin North Am"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","volume":"32","author":"DJ Helfrich","year":"1989","unstructured":"Helfrich DJ, Banner B, Steen VD: Normotensive renal failure in systemic sclerosis. Arthritis Rheum 1989, 32:1128.","journal-title":"Arthritis Rheum"},{"key":"59_CR5","first-page":"1003","volume-title":"Pathology of the Kidney","author":"Z Laszik","year":"1998","unstructured":"Laszik Z, Silva FG: Hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura, and systemic scleroiss. In Pathology of the Kidney, edn 5. Boston: Little, Brown, and Company Medical Division; 1998:1003\u20131057.","edition":"edn 5"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s100670050132","volume":"18","author":"H Kobayashi","year":"1999","unstructured":"Kobayashi H, Nishimaki T, Kaise S: Immunohistochemical study of endothelin-1 and endothelin-A and B receptors in two patients with scleroderma renal crisis. Clin Rheumatol 1999, 18:425\u2013427.","journal-title":"Clin Rheumatol"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, et al.: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J Clin Invest 2003, 111:649\u2013658. Groundbreaking study showing that increased production of soluble flt1 contributes to renal disease of pre-eclampsia in a mouse model, with documentation of increased levels in pateints with pre-eclampsia.","journal-title":"J Clin Invest"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1096\/fasebj.7.9.8330681","volume":"7","author":"CQ Lin","year":"1993","unstructured":"Lin CQ, Bissel MJ: Multi-faced regulation of cell differentiation by extracellular matrix. FASEB 1993, 7:737\u2013743.","journal-title":"FASEB"},{"key":"59_CR9","unstructured":"Black CM, Denton CP: Pathogenesis of scleroderma. Available at http:\/\/www.uptodate.com."},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/hy09t1.094234","volume":"38","author":"SA Mezzano","year":"2001","unstructured":"Mezzano SA, Marta RO, Egido J: Angiotensin II and renal fibrosis. Hypertension 2001, 38:635\u2013638.","journal-title":"Hypertension"},{"key":"59_CR11","first-page":"69","volume":"31","author":"AB Fogo","year":"2001","unstructured":"Fogo AB: Renal fibrosis and the renin-angiotensin system. Adv Nephrol 2001, 31:69\u201387.","journal-title":"Adv Nephrol"},{"key":"59_CR12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.RES.83.12.1182","volume":"83","author":"H Matsubara","year":"1998","unstructured":"Matsubara H: Pathophysiological role of angiotensin type 2 receptor cellular immune responses through a calcineurindependent pathway. Circ Res 1998, 83:1182\u20131191.","journal-title":"Circ Res"},{"key":"59_CR13","first-page":"S30","volume":"10","author":"R Ardaillou","year":"1999","unstructured":"Ardaillou R: Ang II receptors. J Am Soc Nephrol 1999, 10:S30-S39.","journal-title":"J Am Soc Nephrol"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1523-1755.2000.00160.x","volume":"58","author":"S Nakamura","year":"2000","unstructured":"Nakamura S, Nakamura L, Ma L, et al.: Plasminogen activator inhibitor-I expression is regulated by the angiotensin type I receptor in vivo. Kidney Int 2000, 58:251\u2013259.","journal-title":"Kidney Int"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","volume":"10","author":"M Ruiz-Oretega","year":"2001","unstructured":"Ruiz-Oretega M, Lorenzo O, Suzuki Y: Proinflammatory actions of Ang II. Curr Opin Nephrol Hypertens 2001, 10:321\u2013329.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"59_CR16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.HYP.0000084370.74777.B6","volume":"42","author":"EL Schriffin","year":"2003","unstructured":"Schriffin EL, Amiri F, Benkirane K: Peroxisome proliferatoractiviated receptors vascular and cardiac effects in hypertension. Hypertension 2003, 42:664\u2013668.","journal-title":"Hypertension"},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.HYP.0000037969.41360.CC","volume":"40","author":"QN Diep","year":"2002","unstructured":"Diep QN, Amiri F: PPARa activiator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 2002, 40:866\u2013871.","journal-title":"Hypertension"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1523-1755.2001.00766.x","volume":"60","author":"Y Guan","year":"2001","unstructured":"Guan Y, Breyer MD: Peroxisome proliferators-activated receptors (RRPARs): novel therapeutic targets in renal disease. Kidney Int 2001, 60:14\u201330.","journal-title":"Kidney Int"},{"key":"59_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1053\/snep.2002.34725","volume":"22","author":"NJ Brown","year":"2002","unstructured":"Brown NJ, Vaughan DE, Fogo AB: The renin-angiotensinaldosterone system and fibrinolysis in progressive renal disease. Semin Nephrol 2002, 22:399\u2013406. Authoritative review of the renin-angiotensin-aldosterone axis as well as PAI-1 in renal disease.","journal-title":"Semin Nephrol"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/ki.1992.103","volume":"41","author":"M Davies","year":"1992","unstructured":"Davies M, Martin J, Thomas GJ: Proteinases and glomerular matrix turnover. Kidney Int 1992, 41:671\u2013678.","journal-title":"Kidney Int"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ki.1997.190","volume":"51","author":"WA Border","year":"1997","unstructured":"Border WA, Noble NA: TGF-B in kidney fibrosis: a target for gene therapy. Kidney Int 1997, 51:1388\u20131396.","journal-title":"Kidney Int"},{"key":"59_CR22","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1073\/pnas.120055097","volume":"97","author":"F Ziyadeh","year":"2000","unstructured":"Ziyadeh F, Hoffman B, Han D, et al.: Long-term prevention of renal insufficiency excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor-beta antibody in db\/db diabetic mice. Proc Natl Acad Sci U S A 2000, 97:8015\u20138020. First description of the use of an anti-TGF-\u03b2 strategy in a model of spontaneous progressive kidney disease, with relevance to human disease.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"59_CR23","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1046\/j.1523-1755.2003.00009.x","volume":"63","author":"KI Tsuchida","year":"2003","unstructured":"Tsuchida KI, Zhu Y, Siva S, et al.: Role of Smad4 on TGF-betainduced extracellular matrix stimulation in mesangial cells. Kidney Int 2003, 63:2000\u20132009.","journal-title":"Kidney Int"},{"key":"59_CR24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1074\/jbc.275.3.2063","volume":"275","author":"C Sirard","year":"2000","unstructured":"Sirard C, Kim S, Mirtsos C, et al.: Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling. J Biol Chem 2000, 275:2063\u20132070.","journal-title":"J Biol Chem"},{"key":"59_CR25","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/S0012-3692(15)38703-1","volume":"120","author":"AB Roberts","year":"2001","unstructured":"Roberts AB, Piek E, Bottinger EP, et al.: Is Smad3 a major player in signal transduction pathways leading to fiborgenesis. Chest 2001, 120:43S-47S.","journal-title":"Chest"},{"key":"59_CR26","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1172\/JCI200319270","volume":"112","author":"M Sato","year":"2003","unstructured":"Sato M, Muragaki Y, Saika S, et al.: Targeted disruption of TGF-b1\/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003, 112:1486\u20131494. Excellent study showing the almost complete abrogation of tubulointerstitial fibrosis and epithelial-mesnechymal trasnformation in a well-accepted murine model of renal interstitial fibrosis.","journal-title":"J Clin Invest"},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/01.ASN.0000067632.04658.B8","volume":"14","author":"HY Lan","year":"2003","unstructured":"Lan HY, Mu W, Tomita N, et al.: Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microobubble system in rat UUO model. J Am Soc Nephrol 2003, 14:1535\u20131548. Elegant study with a novel ultrasound technique showing increased Smad7 is an effective inhibitor of fibrosis in a rat model of renal fibrosis.","journal-title":"J Am Soc Nephrol"},{"key":"59_CR28","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/art.11157","volume":"48","author":"Y Mori","year":"2003","unstructured":"Mori Y, Chen YJ, Varga J: Expression and regulation of intracellular Smad signaling in scleroderma skin fibroblasts. Arthritis Rheum 2003, 48:1964\u20131978.","journal-title":"Arthritis Rheum"},{"key":"59_CR29","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.062010399","volume":"99","author":"C Dong","year":"2002","unstructured":"Dong C, Zhu S, Wang T, et al.: Deficient Smad7 expression: a putative molecular defect in scleroderma. PNAS 2002, 99:3908\u20133913.","journal-title":"PNAS"},{"key":"59_CR30","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1046\/j.1523-1755.2000.00420.x","volume":"58","author":"S Ledbetter","year":"2002","unstructured":"Ledbetter S, Kurtzberg L, Doyle S, et al.: Renal fibrosis in mice treated with human recombinant transforming growth factor-B2. Kidney Int 2002, 58:2367\u20132376.","journal-title":"Kidney Int"},{"key":"59_CR31","doi-asserted-by":"crossref","unstructured":"Sharma K, Deelman L, Madesh M, et al.: Involvement of transforming growth factor-b in regulation of calcium transients in diabetic vascular smooth muscle cells. Am J Physiol Renal Physiol 2003, in press.","DOI":"10.1152\/ajprenal.00145.2003"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1523-1755.2001.059002498.x","volume":"59","author":"M Islam","year":"2000","unstructured":"Islam M, Burke J, McGowan T, et al.: Effect of anti-transforming growth factor-b antibodies in cylcosporine-induced renal dysfunction. Kidney Int 2000, 59:498\u2013506.","journal-title":"Kidney Int"},{"key":"59_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1681\/ASN.V11125","volume":"11","author":"BL Riser","year":"2000","unstructured":"Riser BL, Denichilo M, Cortes P, et al.: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000, 11:25\u201338.","journal-title":"J Am Soc Nephrol"},{"key":"59_CR34","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2337\/diacare.26.9.2632","volume":"26","author":"RE Gilbert","year":"2003","unstructured":"Gilbert RE, Akdeniz A, Weitz S, et al.: Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy. Diabetes Care 2003, 26:2632\u20132636.","journal-title":"Diabetes Care"},{"key":"59_CR35","doi-asserted-by":"crossref","first-page":"F707","DOI":"10.1152\/ajprenal.00007.2002","volume":"283","author":"E Gore-Hyer","year":"2002","unstructured":"Gore-Hyer E, Shegogue D, Markiewicz M, et al.: TGF-B and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 2002, 283:F707-F716.","journal-title":"Am J Physiol Renal Physiol"},{"key":"59_CR36","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1074\/jbc.M010149200","volume":"276","author":"A Holmes","year":"2000","unstructured":"Holmes A, Abraham DJ, Sa S, et al.: CTGF and Smads: maintenance of scleroderma phenotype is independent of Smad signaling. J Biol Chem 2000, 276:10594\u201310601.","journal-title":"J Biol Chem"},{"key":"59_CR37","doi-asserted-by":"crossref","first-page":"45888","DOI":"10.1074\/jbc.M105490200","volume":"276","author":"M Fu","year":"2001","unstructured":"Fu M, Zhang J, Zhu X, et al.: Peroxisome proliferator-activated receptor-y inhibits transforming growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 2001, 276:45888\u201345894.","journal-title":"J Biol Chem"},{"key":"59_CR38","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","volume":"44","author":"P Sambo","year":"2001","unstructured":"Sambo P, Baroni SS, Luchetti M, et al.: Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. [comment]. Arthritis Rheum 2001, 44:2653\u20132664.","journal-title":"Arthritis Rheum"},{"key":"59_CR39","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","volume":"108","author":"M Ruperez","year":"2003","unstructured":"Ruperez M, Lorenzo O, Blanco-Colio LM, et al.: Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 2003, 108:1499\u20131505. An important study showing the link between Ang II and CTGF in vascular smooth muscle cells. This study may underlie some of the non-blood pressure, reno-protective effects of ACE inhibitors in renal and cardiovascular diseases.","journal-title":"Circulation"},{"key":"59_CR40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-9440(10)63689-9","volume":"163","author":"J Yang","year":"2003","unstructured":"Yang J, Dai C, Liu Y: Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Path 2003, 163:621\u2013632.","journal-title":"Am J Path"},{"key":"59_CR41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1172\/JCI200317913","volume":"112","author":"Y Li","year":"2003","unstructured":"Li Y, Yang J, Dai C, et al.: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrosis. J Clin Invest 2003, 112:503\u2013516. Excellent study showing a critical role for TGF-\u03b2-induced ILK in several models of renal disease, including diabetes.","journal-title":"J Clin Invest"},{"key":"59_CR42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)61568-1","volume":"349","author":"FJ Caskey","year":"1997","unstructured":"Caskey FJ, Thacker EJ, Johnston PA, et al.: Failure of losartan to control blood pressure in scleroderma renal crisis. Lancet 1997, 349:620.","journal-title":"Lancet"},{"key":"59_CR43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ndt\/11.supp7.4","volume":"11","author":"D Tsakiris","year":"1996","unstructured":"Tsakiris D, Simpson HK, Jones EG, et al.: Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 1996, 11:4.","journal-title":"Nephrol Dial Transplant"},{"key":"59_CR44","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/ajkd.2001.24516","volume":"37","author":"AJ Bleyer","year":"2001","unstructured":"Bleyer AJ, Donaldson L, McIntosh M: Relationship between underlying renal disease and renal transplantation outcome. Am J Kidney Dis 2001, 37:1152\u20131157.","journal-title":"Am J Kidney Dis"},{"key":"59_CR45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00005792-199911000-00003","volume":"78","author":"YJ Chang","year":"1999","unstructured":"Chang YJ, Spiera H: Renal transplantation in scleroderma. Medicine 1999, 78:382.","journal-title":"Medicine"},{"key":"59_CR46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0002-9610(77)90170-2","volume":"133","author":"GE Merino","year":"1977","unstructured":"Merino GE, Sutherland DE, Kjellstrand CM, et al.: Renal transplantation for progressive systemic sclerosis with renal failure: case report and review of previous experience. Am J Surg 1977, 133:745.","journal-title":"Am J Surg"},{"key":"59_CR47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.102.4.411","volume":"102","author":"DJ Williamson","year":"2000","unstructured":"Williamson DJ, Wallman LL, Jones R, et al.: Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with pulmonary hypertension. Circulation 2000, 102:411\u2013418.","journal-title":"Circulation"},{"key":"59_CR48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","volume":"358","author":"RN Channick","year":"2001","unstructured":"Channick RN, Simonneau G, Sitbon O, et al.: Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebocontrolled study [comment]. Lancet 2001, 358:1119\u20131123.","journal-title":"Lancet"},{"key":"59_CR49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1046\/j.1523-1755.2001.0590041304.x","volume":"59","author":"S Mizuno","year":"2000","unstructured":"Mizuno S, Matsumoto K, Nakamura T: Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 2000, 59:1304\u20131314.","journal-title":"Kidney Int"},{"key":"59_CR50","doi-asserted-by":"crossref","first-page":"F1060","DOI":"10.1152\/ajprenal.00191.2002","volume":"285","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg M, Bottiglio C, Kumar N, et al.: Bone morphogenetic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 2003, 285:F1060-F1067.","journal-title":"Am J Physiol Renal Physiol"},{"key":"59_CR51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1172\/JCI12020","volume":"108","author":"R Stratton","year":"2001","unstructured":"Stratton R, Shiwen X, Martini G, et al.: Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001, 108:241\u2013250.","journal-title":"J Clin Invest"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-004-0059-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-004-0059-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-004-0059-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T13:56:53Z","timestamp":1628949413000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-004-0059-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s11926-004-0059-3","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}